Wednesday, 05 Nov 2025

MedPulse360

The Role of Dystrophin Restoration and Gene Therapy in Cardiac and Pulmonary Function
14 September, 2025

Therapies to Preserve Function and Quality of Life
14 September, 2025

Regeneron to Submit Application for Cemdisiran in Myasthenia Gravis Following Positive Phase 3 NIMBLE Data
14 September, 2025

NPTX2 Identified as Synaptic Biomarker Implicated in ALS Survival, Disease Progression
14 September, 2025

Analyzing Zorevunersen in Phase 3 Registrational Study for Dravet Syndrome: The EMPEROR Trial
14 September, 2025

This Week on NeurologyLive® — August 25, 2025
14 September, 2025

Solriamfetol for Treatment of EDS in Patients With OSA
14 September, 2025

Emerging Treatments for EDS in Patients With OSA
14 September, 2025

Efgartigimod Aims to Become First Therapy for Seronegative Generalized Myasthenia Gravis Following Positive Phase 3 Data
14 September, 2025

COYA 302 Heads to Phase 2 Trial of ALS Following IND Acceptance
14 September, 2025
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago